Healthcare provider profile · identity verified

Jerzy A Sopala, MD

Allopathic & Osteopathic Physicians|Internal Medicine · ASHEBORO, NC · NPI 1629055033

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jerzy A Sopala, MD received $24.12 in general payments during 2025 across 1 reported records.

Enterra Medical, Inc. accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$24.12

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Enterra Medical, Inc.	Unresolved — no canonical attribution shown	$24.12	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$24.12	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	737	85
Furosemide	Furosemide	653	101
Eliquis	Apixaban	406	50
Atorvastatin Calcium	Atorvastatin Calcium	378	82
Potassium Chloride	Potassium Chloride	329	59
Amlodipine Besylate	Amlodipine Besylate	300	70
Gabapentin	Gabapentin	251	53
Metoprolol Succinate	Metoprolol Succinate	215	35
Losartan Potassium	Losartan Potassium	193	43
Tamsulosin Hcl	Tamsulosin Hcl	183	45
Jardiance	Empagliflozin	177	15
Metoprolol Tartrate	Metoprolol Tartrate	173	41
Carvedilol	Carvedilol	165	39
Citalopram Hbr	Citalopram Hydrobromide	160	30
Memantine Hcl	Memantine Hcl	152	17
Sertraline Hcl	Sertraline Hcl	150	30
Lisinopril	Lisinopril	146	35
Duloxetine Hcl	Duloxetine Hcl	140	21
Januvia	Sitagliptin Phosphate	132	14
Oxycodone Hcl	Oxycodone Hcl	122	35
Mirtazapine	Mirtazapine	117	31
Quetiapine Fumarate	Quetiapine Fumarate	114	18
Torsemide	Torsemide	105	23
Clopidogrel	Clopidogrel Bisulfate	104	25
Hydralazine Hcl	Hydralazine Hcl	103	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	103	21
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	99	49
Xarelto	Rivaroxaban	99	13
Metformin Hcl	Metformin Hcl	96	16
Prednisone	Prednisone	94	38
Levetiracetam	Levetiracetam	91	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	89	56
Escitalopram Oxalate	Escitalopram Oxalate	88	22
Ceftriaxone	Ceftriaxone Sodium	87	36
Pantoprazole Sodium	Pantoprazole Sodium	87	55
Divalproex Sodium	Divalproex Sodium	86	17
Donepezil Hcl	Donepezil Hcl	86	17
Doxycycline Hyclate	Doxycycline Hyclate	86	41
Ropinirole Hcl	Ropinirole Hcl	82	12
Alprazolam	Alprazolam	79	16
Famotidine	Famotidine	78	20
Levofloxacin	Levofloxacin	78	44
Tramadol Hcl	Tramadol Hcl	78	25
Myrbetriq	Mirabegron	74	suppressed
Fluticasone Propionate	Fluticasone Propionate	72	25
Pregabalin	Pregabalin	71	12
Clonidine Hcl	Clonidine Hcl	68	14
Rosuvastatin Calcium	Rosuvastatin Calcium	68	14
Simvastatin	Simvastatin	67	14
Buspirone Hcl	Buspirone Hcl	64	13
Nyamyc	Nystatin	64	27
Finasteride	Finasteride	61	suppressed
Omeprazole	Omeprazole	60	31
Trazodone Hcl	Trazodone Hcl	60	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	56	37
Montelukast Sodium	Montelukast Sodium	56	12
Bethanechol Chloride	Bethanechol Chloride	54	12
Lamotrigine	Lamotrigine	51	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	49	suppressed
Ondansetron Hcl	Ondansetron Hcl	49	38
Triamcinolone Acetonide	Triamcinolone Acetonide	49	19
Lidocaine Hcl	Lidocaine Hcl	48	30
Santyl	Collagenase Clostridium Hist.	46	suppressed
Alendronate Sodium	Alendronate Sodium	45	suppressed
Baclofen	Baclofen	44	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	42	suppressed
Bupropion Xl	Bupropion Hcl	41	suppressed
Cephalexin	Cephalexin	41	20
Entresto	Sacubitril/Valsartan	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	40	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	13
Nystop	Nystatin	40	23
Xtampza Er	Oxycodone Myristate	40	suppressed
Latanoprost	Latanoprost	39	14
Allopurinol	Allopurinol	38	13
Fluconazole	Fluconazole	37	19
Nystatin	Nystatin	37	18
Spironolactone	Spironolactone	37	15
Hydrocortisone	Hydrocortisone	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Lactulose	Lactulose	33	14
Lorazepam	Lorazepam	33	18
Azithromycin	Azithromycin	32	18
Diltiazem 24hr Er	Diltiazem Hcl	31	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Glipizide	Glipizide	31	suppressed
Linzess	Linaclotide	31	suppressed
Ondansetron Odt	Ondansetron	31	15
Digoxin	Digoxin	30	suppressed
Methocarbamol	Methocarbamol	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Incruse Ellipta	Umeclidinium Bromide	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Olanzapine Odt	Olanzapine	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	17
Hydrochlorothiazide	Hydrochlorothiazide	26	suppressed
Risperidone	Risperidone	26	suppressed
Sodium Chloride	0.9 % Sodium Chloride	26	14
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Cardura Xl	Doxazosin Mesylate	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Metronidazole	Metronidazole	23	16
Pravastatin Sodium	Pravastatin Sodium	23	11
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Cefdinir	Cefdinir	21	15
Colestipol Hcl	Colestipol Hcl	21	suppressed
Ertapenem	Ertapenem Sodium	21	12
Benazepril Hcl	Benazepril Hcl	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Morphine Sulfate	Morphine Sulfate	20	17
Mupirocin	Mupirocin	20	11
Oxycontin	Oxycodone Hcl	20	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Nitroglycerin	Nitroglycerin	18	18
Restasis	Cyclosporine	18	suppressed
Valsartan	Valsartan	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Midodrine Hcl	Midodrine Hcl	17	13
Olanzapine	Olanzapine	17	suppressed
Oxcarbazepine	Oxcarbazepine	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	12
Topiramate	Topiramate	16	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Leflunomide	Leflunomide	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	13	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Travoprost	Travoprost	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Vancomycin Hcl	Vancomycin Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Estradiol	Estradiol	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$24.12 · 1 records	Enterra Medical, Inc.	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error